Siemens Healthineers has announced the availability of two new blood-based biomarker assays for research use: the Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays. The launch marks an expansion of the company’s brain health research portfolio, with the tests designed to help scientists better understand neurological function and disease … Read more
Archyde The story of the late Reverend Jesse Jackson, who passed away on February 17, 2026, at the age of 84, highlights a critical challenge in neurological medicine: the difficulty in accurately diagnosing rare and complex conditions. Initially diagnosed with Parkinson’s disease, it was later determined that Jackson actually suffered from progressive supranuclear palsy (PSP), … Read more
Emerging evidence suggests widely used metabolic drugs could influence brain aging pathways, yet large clinical trials are still needed to confirm whether they truly alter the course of neurodegenerative disease. Study: The promise of GLP-1 receptor agonists for neurodegenerative diseases. Image Credit: Antonio Marca / Shutterstock In a recent review published in the Journal of Clinical … Read more
New longitudinal evidence suggests reproductive history may shape women’s cognitive aging, offering insights into possible protective pathways while highlighting the need for cautious interpretation. Study: Pregnancy and breastfeeding are associated with less later-life cognitive decline in a longitudinal, prospective cohort. Image Credit: ibragimova / Shuttertock A recent study published in the journal Alzheimer’s & Dementia found … Read more
As we age, we begin to lose the connections that wire up our brains-and neuroscientists aren’t sure why. It is increasingly clear, though, that the loss of synapses-the flexible and adaptive relay stations central to our brains’ ability to think, learn, and remember-is central to the rise of cognitive decline and dementia in old age. … Read more
Transthyretin amyloidosis (ATTR) is a rare, progressive and highly aggressive degenerative disease. It is caused by the misfolding of a specific protein, leading to its toxic accumulation in the form of filamentous deposits in various organs. Researchers at the University of Geneva (UNIGE), in collaboration with the Università della Svizzera Italiana (USI), have succeeded for … Read more
One of the hallmarks of Alzheimer’s disease is the clumping of proteins called Tau, which form tangled fibrils in the brain. The more severe the clumping, the more advanced the disease is. The Tau protein, which has also been linked to many other neurodegenerative diseases, is unstructured in its normal state, but in the pathological … Read more
What is the simple secret to living longer and reducing your risks for heart disease, diabetes, and cancer? Mixing up your daily fruits, veggies, and teas suggests an extensive study. Study: High diversity of dietary flavonoid intake is associated with a lower risk of all-cause mortality and major chronic diseases. Image credit: marilyn barbone/Shutterstock.com A recent study published … Read more
Researchers at the University of São Paulo (USP) in Brazil have succeeded in showing, in an animal model, that the process of insulin resistance in the brain affects both Alzheimer’s disease and epilepsy and may be a linking factor between the two diseases. The work, supported by FAPESP, confirms clinical evidence that people with epilepsy … Read more
Could a common stomach bug help shield the brain from Parkinson’s? New research links H. pylori infection to reduced disease risk, opening fresh avenues in neurodegenerative science. Study: Helicobacter pylori infection might be a protective factor against Parkinson’s disease. Image Credit: Liya Graphics / Shutterstock Around half the world has Helicobacter pylori infections, which are typically linked to … Read more